-transparent.png){kind=logo}
Male and female patas (Erythrocebus patas) and cynomolgus (Macaca fascicularis) monkeys were treated with phenobarbitone (PB) and examined for the induction of various cytochrome P450 (P450)-mediated drug metabolizing enzymes. Hydroxylation of testosterone at the 6 beta, 2 beta, and 15 beta positions, metabolites normally associated with CYP3A P450s increased 2- to 5-fold in PB-treated animals. Induction of this P450 family was confirmed by the use of polyclonal antisera directed against the human CYP3A enzymes which inhibited both induced and constitutive 6 beta- and 15 beta-hydroxylase activities in both species of monkeys. The enzymatic activities testosterone 16 beta-hydroxylation, pentoxyresorufin O-dealkylation [PROD], and benzyloxyresorufin O-dealkylation [BZROD] typically associated with the rodent CYP2B subfamily in rodents were also examined. Testosterone 16 beta-hydroxylation activity was highly induced up to 15-fold in both species of monkeys to maximal levels similar to those induced in PB-treated male rats. BZROD was similarly induced up to 10-fold in both species of monkeys, but the maximal levels of BZROD achieved were substantially lower than those obtained in PB-treated rats. Finally, PROD yielded an idiosyncratic response showing substantial induction (> 30-fold) in certain patas monkeys (4 out of 8) but minimal (< 5-fold) induction in the other patas monkeys (4 out of 8) or any of the cynomolgus monkeys (0 out of 8). Immunodetection of various cytochromes using polyclonal antisera directed against rat cytochromes confirmed the induction of CYP3A proteins as well as the induction of protein(s) immunologically cross-reactive with rat CYP2B P450s. BZROD, PROD, or testosterone 16 beta-hydroxylase activities, were not inhibited by antibody to CYP3A P450s. However, high concentrations of polyclonal antiserum directed against rat CYP2B inhibited all three activities in PB-induced patas monkeys. In contrast, this antiserum failed to inhibit the hydroxylation of testosterone at the 6 beta or 2 beta positions. Induction of the CYP2C subfamily was observed by immunochemical detection. Interestingly, induction of this subfamily appeared to be more pronounced in cynomolgus than in patas monkeys. Finally, we failed to observe significant sex-dependent differences in P450-mediated enzymatic activities in either control or induced monkeys. These results confirm the induction of a similar spectrum of P450 proteins by PB in non-human primates to that which has previously been observed in rodents.
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
January 2020,
Current drug metabolism,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
January 2003,
Biomeditsinskaia khimiia,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
October 2001,
Drug metabolism and disposition: the biological fate of chemicals,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
July 2004,
Xenobiotica; the fate of foreign compounds in biological systems,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
June 1998,
Chemico-biological interactions,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
January 2022,
Advances in pharmacology (San Diego, Calif.),
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
April 2004,
Toxicology and applied pharmacology,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
May 1999,
Toxicology and applied pharmacology,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
October 2008,
Toxicology,
C R Jones, and
F P Guengerich, and
J M Rice, and
R A Lubet
January 1993,
The Journal of pharmacology and experimental therapeutics,
